Abstract 4516: SA-4-1BBL as a novel agonist of CD137 has immunoprevention efficacy against various tumor types

Authors: Haval Shirwan, Lalit Batra, Mohammad Tariq Malik, Pradeep Shrestha, Jenci L. Hawthorne, Esma S. Yolcu

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-4516

Source: Full article